PC-Tel, Inc. Common StockUnderwriting Agreement • September 17th, 1999 • Pc Tel Inc • Services-computer programming, data processing, etc. • New York
EXHIBIT 10.5 Security Agreement dated as of May 2004 between Silicon Film Technologies, Inc. and Cornell Capital Partners, LP SECURITY AGREEMENT ------------------ THIS SECURITY AGREEMENT (the "AGREEMENT"), is entered into and made effective as of May...Security Agreement • March 30th, 2005 • Voyager One Inc • Photographic equipment & supplies • New Jersey
The initial public offering price per share for the Shares and the purchase price per share for the Shares to be paid by the several Underwriters shall be agreed upon by the Company and the Representatives, acting on behalf of the several...Underwriting Agreement • October 11th, 1996 • Alanex Corp • Services-commercial physical & biological research • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • August 24th, 2000 • Radiance Medical Systems Inc /De/ • Surgical & medical instruments & apparatus • New York
OVERLAND DATA, INC. 3,105,000 SHARES COMMON STOCK ($0.001 PAR VALUE) UNDERWRITING AGREEMENTUnderwriting Agreement • January 24th, 1997 • Overland Data Inc • Computer storage devices • New York
Kronos Bio, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • October 5th, 2020 • Kronos Bio, Inc. • Pharmaceutical preparations • New York
Kronos Bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares of the Company’s common stock, par value $0.001 per share (“Stock, and such shares ”the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
IMMUNEERING CORPORATION EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 10th, 2022 • Immuneering Corp • Pharmaceutical preparations • New York
As further set forth in this agreement (this “Agreement”), Immuneering Corporation, a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s Class A common stock, $0.001 par value per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on the terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.
LICENSE AND ROYALTY AGREEMENT THIS AGREEMENT, made and entered into this 6th day of April, 2000, by and between Richard L. Ballard and Janet J. Pettitt, husband and wife, (referred to herein as "Ballard"), and Knowledge Foundations, Inc., a Delaware...License Agreement • September 27th, 2000 • Knowledge Foundations Inc/De • Services-business services, nec • California
SOMAXON PHARMACEUTICALS, INC. Common Stock ($0.0001 par value per share) AT- THE-MARKET EQUITY OFFERING SALES AGREEMENTAt-the-Market Equity Offering Sales Agreement • August 2nd, 2011 • Somaxon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Somaxon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time to or through Citadel Securities LLC (“Citadel”), as sales agent and/or principal (“Agent”), shares (the “Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), having an aggregate offering price of up to $30,000,000 on the terms set forth in Section 2 of this Sales Agreement (the “Agreement”). The Company agrees that whenever it determines to sell Shares directly to the Agent as principal, it will enter into a separate agreement (each, a “Terms Agreement”) in substantially the form of Annex I hereto, relating to such sale in accordance with Section 3 of this Agreement.
EXHIBIT 2.2 ASSET PURCHASE AGREEMENT ------------------------ THIS ASSET PURCHASE AGREEMENT is made and entered at Hinsdale, Illinois, on February 1, 2003, by and between QUEST MANUFACTURING, INC. an Illinois corporation ("Seller"), and SILICON FILM...Asset Purchase Agreement • March 31st, 2005 • Voyager One Inc • Photographic equipment & supplies • Illinois
7852 Colgate Avenue Westminster, CA 92683 December 27, 2002 Mr. Michael Dochterman CEO and President Knowledge Foundations, Inc. Dear Mr. Dochterman: As required in Section 12.7 of License and Royalty Agreement ("Agreement") dated April 6, 2000...License and Royalty Agreement • January 6th, 2003 • Knowledge Foundations Inc/De • Services-prepackaged software
EX-10.5 16 dex105.htm DEVELOPMENT AGREEMENT DEVELOPMENT AGREEMENT BETWEEN BiopolyMed, Inc. And Phage Biotechnology, Inc.Development Agreement • May 5th, 2020 • California
This Development Agreement (Agreement) is dated the 7th day of May, 2004, by and between BiopolyMed, Inc., 711 Korea Techno Complex, 126-16,5-ga, Ananm-dong, Sungbuk-gu, Seoul, Korea 136-701, (“BPM”), and Phage Biotechnology, Inc., 14272 Franklin Avenue, Suite 110, Tustin, California 92780, (Phage) (together “The Parties”).
EXCLUSIVE LICENSE AGREEMENT NUMBER Between REVA Medical, Inc. and RUTGERS, THE STATE UNIVERSITY OF NEW JERSEYExclusive License Agreement • September 21st, 2010 • REVA Medical, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New Jersey
THIS Exclusive License Agreement Number 2 (the “Agreement”) is made and is effective as of the 1st day of June 2010, (the “Effective Date”) by and between Rutgers, The State University Of New Jersey, having its statewide Office of Technology Commercialization at ASB Annex III, 3 Rutgers Plaza, New Brunswick, New Jersey 08901-8559, (hereinafter referred to as “Rutgers”), and REVA Medical, Inc., a California corporation having a principal place of business at 5751 Copley Drive, Suite B, San Diego, CA 92111 (hereinafter referred to as “Licensee”).
EX-10.1 2 dex101.htm COMMERCIAL LEASE OFFICE SUBLEASE AGREEMENT Knobbe, Martens, Olson & Bear, LLP, a California limited liability partnership, as Landlord, and ECC Capital Corporation, a Maryland corporation, as Tenant IRVINE, CALIFORNIA Office Lease...Sublease Agreement • May 5th, 2020
EX-10.30 35 dex1030.htm SETTLEMENT AGREEMENT AND RELEASE OF CLAIMS, DATED 01/17/2006 SETTLEMENT AGREEMENT AND RELEASE OF CLAIMSSettlement Agreement • May 5th, 2020 • California
This Settlement Agreement and Release of Claims (the “Agreement”) is made and entered into this 17th day of January, 2006, between Masimo Corporation and Masimo Laboratories, Inc. (hereinafter “Masimo”), and Nellcor Puritan Bennett, Inc., Mallinckrodt, Inc, Tyco Healthcare Group LP, Tyco International Ltd, and Tyco International (US) Inc. (collectively “Nellcor”) (each individually as a “Party” or collectively the “Parties”).
EX-10.2 2 rva-ex102_737.htm EX-10.2 EXCLUSIVE LICENSE AGREEMENT NUMBER Between REVA Medical, Inc. and RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY EXCLUSIVE LICENSE AGREEMENT NUMBER 2Exclusive License Agreement • May 5th, 2020 • New Jersey
THIS Exclusive License Agreement Number 2 (the "Agreement") is made and is effective as of the 1st day of July 2010, (the “Effective Date”) by and between Rutgers, The State University Of New Jersey, having its statewide Office of Technology Commercialization at ASB Annex III, 3 Rutgers Plaza, New Brunswick, New Jersey 08901-8559, (hereinafter referred to as "Rutgers"), and REVA Medical, Inc., a California corporation having a principal place of business at 5751 Copley Drive, Suite B, San Diego, CA 92111 (hereinafter referred to as "Licensee").
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • December 27th, 2007 • EncryptaKey, Inc. • Measuring & controlling devices, nec • Nevada
THIS ASSET PURCHASE AGREEMENT (this "Agreement") is made and entered into as of November 15, 2007, by and between EncryptaKey, Inc., a New Jersey Corporation ("Seller"), and EncryptaKey, Inc., a Nevada corporation ("Buyer").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 28th, 2009 • Freestone Resources, Inc. • Services-business services, nec • Nevada
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into by and between (i) Freestone Resources, Inc. (“Freestone”), a Nevada corporation, (ii) Environmental Services and Support, Inc. (“Enviro Serv”), a California corporation, and Lawrence Shultz (“Shultz”), an individual, the sole shareholders of all of the issued and outstanding stock of Earth Oil Services, Inc. (“EOSI”), a Nevada corporation.
SETTLEMENT AGREEMENT AND RELEASE OF CLAIMSSettlement Agreement • May 9th, 2006 • Tyco International LTD /Ber/ • Electronic connectors • California
PATENT LICENSE AGREEMENTPatent License Agreement • February 10th, 2012 • Discount Dental Materials, Inc. • Wholesale-medical, dental & hospital equipment & supplies • California
This Patent License Agreement (the “Agreement”) is hereby entered into effective as of June 10, 2010 (the “Effective Date”), by and between Cerebain Biotech Corp., a California corporation, (hereinafter “Cerebain”) located at 92 Corporate Park, C-141, Irvine, CA 92606, and Dr. Surinder Singh Saini, MD, an individual (hereinafter “Licensor”) located at 1280 Bison Ave., B9-41, Newport Beach, CA 92657. Cerebain and Licensor may each be referred to herein as a “Party” and together as the “Parties.”
REVOLVING CREDIT AGREEMENT between CESCA THERAPEUTICS INC. “Borrower” and BOYALIFE INVESTMENT FUND II, INC. “Lender”Revolving Credit Agreement • March 10th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
THIS AGREEMENT (this “Agreement”), dated as of March 6, 2017 (the “Effective Date”), is made between CESCA THERAPEUTICS INC., a Delaware corporation (“Borrower”), and BOYALIFE INVESTMENT FUND II, INC., an Illinois corporation (“Lender”).
MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • October 14th, 2014 • Compass Group Diversified Holdings LLC • Motor vehicle parts & accessories • California
This MEMBERSHIP INTEREST PURCHASE AGREEMENT is entered into as of the 10th day of October, 2014 by and among CANDLE LAMP HOLDINGS, LLC, a Delaware limited liability company (“Seller”), CANDLE LAMP COMPANY, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Seller (the “Company”), and SternoCandleLamp Holdings, Inc., a Delaware corporation (“Purchaser”). Each of Westar Capital Associates II, LLC, a Delaware limited liability company (“Westar”), and the Argyros Family Trust (“Argyros Trust”), is a party hereto only for purposes of Section 6.9 and Section 10.11 below. Compass Group Diversified Holdings LLC, a Delaware limited liability company and the parent of Purchaser (“Parent”), is a party hereto only for purposes of Section 10.4(c) and Section 10.10 below. Each of the Seller Guaranty Parties named on Schedule 10.11 and identified on the signature pages hereto is a party hereto only for purposes of Section 10.11 below.
MEMOGAIN TECHNOLOGY LICENCE AGREEMENTTechnology License Agreement • April 30th, 2024 • Alpha Cognition Inc. • Biological products, (no disgnostic substances) • British Columbia
NOW THEREFORE THIS AGREEMENT WITNESSETH that in consideration of the premises and of the mutual covenants herein set forth, the parties hereto have covenanted and agreed as follows:
